Status:
COMPLETED
Évaluation de l'Impact du Compressed Sensing Sur le Signal QSM
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
MRI
Eligibility:
All Genders
18+ years
Brief Summary
Patients who have agreed to participate in the study will complete the MRI protocol as part of routine care, to which a maximum of four additional 25-minute sequences will be added. MRI of routine ca...
Detailed Description
Patients who have agreed to participate in the study will complete the MRI protocol as part of routine care, to which a maximum of four additional 25-minute sequences will be added. MRI of routine ca...
Eligibility Criteria
Inclusion
- For patients with MS:
- Patient over 18 years old
- Presenting MS defined according to McDonald's revised criteria for spatial and temporal clinical or radiological dissemination \[16\],
- Should benefit as part of the care of an MRI examination with or without injection of gadolinium
- Express consent to participate in the study
- Affiliate or beneficiary of a social security scheme
- For patients with an indication to undergo a brain MRI and at low risk of inflammatory CNS disease:
- Patient over 18 years old
- Should benefit as part of the care of an MRI examination with or without injection of gadolinium
- Express consent to participate in the study
- Affiliate or beneficiary of a social security scheme
Exclusion
- For patients with MS:
- Patient benefiting from a legal protection measure
- Pregnant or breastfeeding woman
- For patients with an indication to undergo a brain MRI and at low risk of inflammatory CNS disease:
- Patient benefiting from a legal protection measure
- Pregnant or breastfeeding woman
- Patient with inflammatory and / or demyelinating pathology of the CNS
- Secondary exclusion criteria :
- Motion artefact not allowing interpretation of images
- Patient who did not perform one of the following sequences: 3D T1 TFE, 3D FLAIR (for MS patients), SWI QSM 1.0iso 8 echoes.
- Secondarily excluded patients will be replaced.
Key Trial Info
Start Date :
December 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 14 2025
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT04907487
Start Date
December 15 2021
End Date
May 14 2025
Last Update
January 5 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hhopital fondation adolphe de rothschild
Paris, Paris, France, 75019